|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,590.16 |
3.28% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$60,982.50 |
2.88% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$52,035.36 |
2.45% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$51,585.41 |
2.43% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$47,460.90 |
2.24% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$47,531.99 |
2.24% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$47,299.95 |
2.23% |
| Waters Corporation |
WAT |
941848103 |
120 |
$46,250.40 |
2.18% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$45,587.32 |
2.15% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$45,020.41 |
2.12% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$44,941.82 |
2.12% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$44,784.16 |
2.11% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$44,822.15 |
2.11% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,286.91 |
2.09% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$44,363.40 |
2.09% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$43,827.34 |
2.07% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$43,786.57 |
2.07% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$43,637.05 |
2.06% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$43,769.16 |
2.06% |
| Steris Plc |
STE |
G8473T100 |
169 |
$42,937.83 |
2.03% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$42,819.26 |
2.02% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$42,453.81 |
2.00% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$42,324.48 |
2.00% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$41,956.51 |
1.98% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$41,261.28 |
1.95% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$41,322.72 |
1.95% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$41,055.20 |
1.94% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$41,202.26 |
1.94% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$40,226.76 |
1.90% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$40,140.60 |
1.89% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$38,913.03 |
1.84% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$38,728.79 |
1.83% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$38,669.47 |
1.82% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$38,535.42 |
1.82% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$38,527.08 |
1.82% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$38,170.25 |
1.80% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$37,951.81 |
1.79% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$37,922.40 |
1.79% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$38,018.09 |
1.79% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$38,000.38 |
1.79% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$37,756.02 |
1.78% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$37,768.54 |
1.78% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$37,688.07 |
1.78% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$37,021.77 |
1.75% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,201.29 |
1.75% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$36,676.79 |
1.73% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$36,486.33 |
1.72% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$36,290.37 |
1.71% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$35,486.01 |
1.67% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$31,562.65 |
1.49% |
| US Dollar |
$USD |
|
2,873 |
$2,872.57 |
0.14% |
| New Zealand Dollar |
$NZD |
|
506 |
$292.55 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|